Targeting Innate Immunity in Glioma Therapy

Targeting Innate Immunity in Glioma Therapy

Currently, there is a lack of effective therapies for the majority of glioblastomas (GBMs), the most common and malignant primary brain tumor. While immunotherapies have shown promise in treating various types of cancers, they have had limited success in improving the overall survival of GBM patient...

Full description

Bibliographic Details
Main Authors: Andrew G. Gillard, Dong Ho Shin, Lethan A. Hampton, Andres Lopez-Rivas, Akhila Parthasarathy, Juan Fueyo, Candelaria Gomez-Manzano
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:International Journal of Molecular Sciences
Subjects:
innate immunity
glioma
immunotherapy
adaptive therapy
virotherapy
Online Access:https://www.mdpi.com/1422-0067/25/2/947

Similar Items

Similar Items